163 related articles for article (PubMed ID: 36291168)
21. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
22. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.
Freedman BS; Lam AQ; Sundsbak JL; Iatrino R; Su X; Koon SJ; Wu M; Daheron L; Harris PC; Zhou J; Bonventre JV
J Am Soc Nephrol; 2013 Oct; 24(10):1571-86. PubMed ID: 24009235
[TBL] [Abstract][Full Text] [Related]
23. BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage.
Vohhodina J; Goehring LJ; Liu B; Kong Q; Botchkarev VV; Huynh M; Liu Z; Abderazzaq FO; Clark AP; Ficarro SB; Marto JA; Hatchi E; Livingston DM
Nat Commun; 2021 Jun; 12(1):3542. PubMed ID: 34112789
[TBL] [Abstract][Full Text] [Related]
24. Molecular advances in autosomal dominant polycystic kidney disease.
Gallagher AR; Germino GG; Somlo S
Adv Chronic Kidney Dis; 2010 Mar; 17(2):118-30. PubMed ID: 20219615
[TBL] [Abstract][Full Text] [Related]
25. Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.
Obeidova L; Elisakova V; Stekrova J; Reiterova J; Merta M; Tesar V; Losan F; Kohoutova M
BMC Med Genet; 2014 Apr; 15():41. PubMed ID: 24694054
[TBL] [Abstract][Full Text] [Related]
26. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
27. Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients.
Oh YK; Park HC; Ryu H; Kim YC; Oh KH
Korean J Intern Med; 2021 Jul; 36(4):767-779. PubMed ID: 34237823
[TBL] [Abstract][Full Text] [Related]
28. Mutational Screening of PKD1 and PKD2 Genes in Iranian Population Diagnosed with Autosomal Dominant Polycystic Kidney Disease.
Ranjzad F; Tara A; Basiri A; Aghdami N; Moghadasali R
Clin Lab; 2017 Jul; 63(7):1261-1267. PubMed ID: 28792715
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
[TBL] [Abstract][Full Text] [Related]
30. Exon sequencing of PKD1 gene in an Iranian patient with autosomal-dominant polycystic kidney disease.
Hafizi A; Khatami SR; Galehdari H; Shariati G; Saberi AH; Hamid M
Iran Biomed J; 2014 Jul; 18(3):143-50. PubMed ID: 24842140
[TBL] [Abstract][Full Text] [Related]
31. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants.
Raj S; Singh RG; Das P
Mutat Res; 2020; 821():111718. PubMed ID: 32823016
[TBL] [Abstract][Full Text] [Related]
32. Cilia and polycystic kidney disease.
Ma M
Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
[TBL] [Abstract][Full Text] [Related]
33. Autosomal dominant polycystic kidney disease: comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients.
Audrézet MP; Cornec-Le Gall E; Chen JM; Redon S; Quéré I; Creff J; Bénech C; Maestri S; Le Meur Y; Férec C
Hum Mutat; 2012 Aug; 33(8):1239-50. PubMed ID: 22508176
[TBL] [Abstract][Full Text] [Related]
34. Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
Moriyama T; Nakayama Y; Soejima M; Yokota Y; Ota K; Ito S; Kodama G; Nakamura N; Kurokawa Y; Yano J; Ueda U; Takamiya Y; Kaida Y; Hazama T; Shibata R; Koda Y; Fukami K
Clin Exp Nephrol; 2021 Mar; 25(3):251-260. PubMed ID: 33141305
[TBL] [Abstract][Full Text] [Related]
35. The telomere world and aging: Analytical challenges and future perspectives.
Mensà E; Latini S; Ramini D; Storci G; Bonafè M; Olivieri F
Ageing Res Rev; 2019 Mar; 50():27-42. PubMed ID: 30615937
[TBL] [Abstract][Full Text] [Related]
36. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
[TBL] [Abstract][Full Text] [Related]
37. New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease.
Stekrova J; Reiterova J; Svobodova S; Kebrdlova V; Lnenicka P; Merta M; Viklicky O; Kohoutova M
BMC Med Genet; 2009 Aug; 10():78. PubMed ID: 19686598
[TBL] [Abstract][Full Text] [Related]
38. PKD1-Associated Arachnoid Cysts in Autosomal Dominant Polycystic Kidney Disease.
Shigemori K; Higashihara E; Itoh M; Yoshida H; Yamamoto K; Nutahara K; Shiokawa Y; Kaname S; Tambo M; Yamaguchi T; Taguchi S; Yoshioka T; Yokoyama K; Fukuhara H
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105943. PubMed ID: 34175641
[TBL] [Abstract][Full Text] [Related]
39. METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability.
Chen L; Zhang C; Ma W; Huang J; Zhao Y; Liu H
Nucleic Acids Res; 2022 Nov; 50(20):11619-11634. PubMed ID: 36399511
[TBL] [Abstract][Full Text] [Related]
40. Is it Time to Fold the Cysts Away?
Krappitz M; Gallagher AR; Fedeles S
Trends Mol Med; 2016 Dec; 22(12):997-999. PubMed ID: 27793600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
